Long-term anti-hypertensive therapy with benidipine improves arterial stiffness over blood pressure lowering

Hypertension Research

Volumn 28, Issue 12, 2005, Pages 959-964

  Kita, Toshihiro ^a   Suzuki, Yoshihiko ^a   Eto, Tanenao ^a   Kitamura, Kazuo ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Benidipine; Blood pressure; Human; Nicardipine; Pulse wave velocity

Indexed keywords

BENIDIPINE; NICARDIPINE;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE CALCULATION; DRUG SAFETY; FEMALE; HUMAN; HYPERTENSION; LONG TERM CARE; MALE; PULSE WAVE; REGRESSION ANALYSIS; SHORT COURSE THERAPY;

ADULT; ANTIHYPERTENSIVE AGENTS; ARTERIES; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIABETES COMPLICATIONS; DIHYDROPYRIDINES; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NICARDIPINE; PULSE; REGRESSION ANALYSIS;

EID: 33644509237     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.28.959     Document Type: Article

References (29)

1. Laurent S, Boutouyrie P, Asmar R, et al: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
2. Blacher J, Asmar R, Djane S, London GM, Safar ME: Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33: 1111-1117.
3. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London ME: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103: 987-992.
4. Kita T, Kitamura K, Hashida S, Morishita K, Eto T: Plasma adrenomedullin is closely correlated with pulse wave velocity in middle-aged and elderly patients. Hypertens Res 2003; 26: 887-893.
5. Imanishi R, Seto S, Toda G, et al: High brachial-ankle pulse wave velocity is an independent predictor of the presence of coronary artery disease in men. Hypertens Res 2004; 27: 71-78.
6. Koji Y, Tomiyama H, Ichihashi H, et al: Comparison of ankle-brachial pressure index and pulse wave velocity as markers of the presence of coronary artery disease in subjects with a high risk of atherosclerotic cardiovascular disease. Am J Cardiol 2004; 94: 868-872.
7. Munakata M, Ito N, Nunokawa T, Yoshinaga K: Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens 2003; 16: 653-657.
8. Matsui Y, Kario K, Ishikawa J, Eguchi K, Hoshide S, Shimada K: Reproducibility of arterial stiffness indices (pulse wave velocity and augmentation index) simultaneously assessed by automated pulse wave analysis and their associated risk factors in essential hypertensive patients. Hypertens Res 2004; 27: 851-857.
9. Munakata M, Sakuraba J, Tayama J, et al: Higher brachial-ankle pulse wave velocity is associated with more advanced carotid atherosclerosis in end-stage renal disease. Hypertens Res 2005; 28: 9-14.
10. Ichihara A, Hayashi M, Koura Y, Toda Y, Hirota N, Saruta T: Long-term effects of intensive blood pressure lowering on arterial wall stiffness in hypertensive patients. Am J Hypertens 2003; 16: 959-965.
11. Munakata M, Nagasaki A, Nunokawa T, et al: Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients. Am J Hypertens 2004; 17: 1050-1055.
12. Agata J, Nagahara D, Kinoshita S, et al: Angiotensin II receptor blocker prevents increased arterial stiffness in patients with essential hypertension. Circ J 2004; 68: 1194-1198.
13. Pitt B, Byington RP, Furberg CD, et al, PREVENT Investigators: Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 2000; 102: 1503-1510.
14. Zanchetti A, Bond MG, Henning M, et al: Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation 2002; 106: 2422-2427.
15. Nissen SE, Tuzcu EM, Libby P, et al: Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 2004; 292: 2217-2225.
16. Dohi Y, Kojima M, Sato K: Benidipine improves endothelial function in renal resistance arteries of hypertensive rats. Hypertension 1996; 28: 58-63.
17. Kobayashi N, Kobayashi K, Kouno K, Yagi S, Matsuoka H: Effect of benidipine on microvascular remodeling and coronary flow reserve in two-kidney, one clip Goldblatt hypertension. J Hypertens 1997; 15: 1285-1294.
18. Yamashita T, Kawashima S, Ozaki M, et al: A calcium channel blocker, benidipine, inhibits intimal thickening in the carotid artery of mice by increasing nitric oxide production. J Hypertens 2001; 19: 451-458.
19. Wilkinson IB, Mohammad NH, Tyrrell S, et al: Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens 2002; 15: 24-30.
20. Benetos A, Adamopoulos C, Bureau J-M, et al: Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over 6-year period. Circulation 2002; 105: 1202-1207.
21. National Intervention Cooperative Study in Elderly Hypertension Study Group: Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. Hypertension 1999; 34: 1129-1133.
22. Tsukiyama H, Kikawada R, Osada H, et al: Safety and efficacy of long-term therapy with benidipine in aged hypertensive patients. Geriat Med 1997; 35: 989-1007 (in Japanese).
23. Ito A, Fukumoto Y, Shimokawa H: Changing characteristics of patients with vasospastic angina in the era of new calcium channel blockers. J Cardiovasc Pharmacol 2004; 44: 480-485.
24. Hayashi K, Ozawa Y, Fujiwara K, Wakino S, Kumagai H, Saruta T: Role of actions of calcium antagonists on efferent arterioles - with special references to glomerular hypertension. Am J Nephrol 2003; 23: 229-244.
25. Kobayashi N, Nakano S, Mori Y, Kobayashi T, Tsubokou Y, Matsuoka H: Benidipine inhibits expression of ET-1 and TGF-β1 in Dahl salt-sensitive hypertensive rats. Hypertens Res 2001; 24: 241-250.
26. Yasunari K, Maeda K, Nakamura M, Watanabe T, Yoshikawa J: Benidipine, a long-acting calcium channel blocker, inhibits oxidative stress in polymorphonuclear cells in patients with essential hypertension. Hypertens Res 2005; 28: 107-112.
27. Pai JK, Pischon T, Ma J, et al: Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004; 351: 2599-2610.
28. Ridker PM, Cannon CP, Morrow D, et al: C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005; 352: 20-28.
29. Takase H, Toriyama T, Sugiyama M, et al: Effect of nifedipine on C-reactive protein levels in the coronary sinus and on coronary blood flow in response to acetylcholine in patients with stable angina pectoris having percutaneous coronary intervention. Am J Cardiol 2005; 95: 1235-1237.